GSK (GSK) RNS Announcements

Add to Alert list

Show entries

Filter by source or headline

Date	Time	Source	Announcement
10 Apr 2006	05:50 PM	RNS	Director/PDMR Shareholding
10 Apr 2006	05:46 PM	RNS	Director/PDMR Shareholding
10 Apr 2006	05:45 PM	RNS	Director/PDMR Shareholding
10 Apr 2006	05:42 PM	RNS	Director/PDMR Shareholding
10 Apr 2006	05:38 PM	RNS	Director/PDMR Shareholding
07 Apr 2006	04:33 PM	RNS	Director/PDMR Shareholding
04 Apr 2006	06:12 PM	RNS	Director/PDMR Shareholding
04 Apr 2006	03:30 PM	RNS	Director/PDMR Shareholding
04 Apr 2006	02:37 PM	RNS	Director/PDMR Shareholding
03 Apr 2006	06:30 PM	RNS	Director/PDMR Shareholding
03 Apr 2006	05:50 PM	RNS	Director/PDMR Shareholding
03 Apr 2006	02:02 PM	RNS	Tykerb Phase III Trial Update
31 Mar 2006	12:55 PM	RNS	Annual Information Update
31 Mar 2006	12:46 PM	RNS	Publication of Prospectus
30 Mar 2006	05:20 PM	RNS	Transaction in Own Shares
30 Mar 2006	03:37 PM	RNS	Director/PDMR Shareholding
29 Mar 2006	05:14 PM	RNS	Transaction in Own Shares
28 Mar 2006	05:26 PM	RNS	Transaction in Own Shares
28 Mar 2006	12:00 PM	RNS	Seretide COPD Study Results
28 Mar 2006	11:26 AM	RNS	Director/PDMR Shareholding
28 Mar 2006	11:24 AM	RNS	Director/PDMR Shareholding
27 Mar 2006	05:11 PM	RNS	Transaction in Own Shares
27 Mar 2006	04:38 PM	RNS	Director/PDMR Shareholding
27 Mar 2006	12:33 PM	RNS	Director/PDMR Shareholding
24 Mar 2006	05:01 PM	RNS	Transaction in Own Shares
24 Mar 2006	04:28 PM	RNS	Director/PDMR Shareholding
24 Mar 2006	02:33 PM	RNS	Director/PDMR Shareholding
23 Mar 2006	05:14 PM	RNS	Transaction in Own Shares
23 Mar 2006	02:58 PM	RNS	Director/PDMR Shareholding
23 Mar 2006	02:00 PM	RNS	Notice of AGM
22 Mar 2006	05:10 PM	RNS	Director/PDMR Shareholding
22 Mar 2006	05:06 PM	RNS	Director/PDMR Shareholding
22 Mar 2006	02:15 PM	RNS	Director/PDMR Shareholding
21 Mar 2006	05:04 PM	RNS	Transaction in Own Shares
21 Mar 2006	01:04 PM	RNS	Director/PDMR Shareholding
20 Mar 2006	05:20 PM	RNS	Director/PDMR Shareholding
20 Mar 2006	05:06 PM	RNS	Transaction in Own Shares
17 Mar 2006	05:34 PM	RNS	Director/PDMR Shareholding
17 Mar 2006	02:26 PM	RNS	Director/PDMR Shareholding
16 Mar 2006	05:33 PM	RNS	Director/PDMR Shareholding
16 Mar 2006	05:05 PM	RNS	Transaction in Own Shares
15 Mar 2006	04:49 PM	RNS	Transaction in Own Shares
14 Mar 2006	05:42 PM	RNS	Director/PDMR Shareholding
14 Mar 2006	05:37 PM	RNS	Director/PDMR Shareholding
14 Mar 2006	05:35 PM	RNS	Director/PDMR Shareholding
14 Mar 2006	04:53 PM	RNS	Transaction in Own Shares
13 Mar 2006	05:17 PM	RNS	Director/PDMR Shareholding
13 Mar 2006	05:13 PM	RNS	Director/PDMR Shareholding
13 Mar 2006	05:10 PM	RNS	Transaction in Own Shares
10 Mar 2006	05:26 PM	RNS	Director/PDMR Shareholding

Showing 4651 to 4700 of 6896 results

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989.

Thursday, 9th January 2025

COMPANIES COVERED:

MKS GRG BME

Marks and Spencer struggles despite posting record pre-Christmas sales, Greggs under fire as inflationary pressures for 2025 grow and B&M Retail rocked by profit guidance tightening, with no concession from special dividend payout.

Full Archive

UK 100

Latest directors dealings

3 minutes ago Judges Scientific
17 minutes ago Rolls-Royce Holdings
47 minutes ago PayPoint
4 hours ago Netcall
4 hours ago Tiger Royalties and Investments

All directors dealings today